Company Profile: Oventus Medical Limited (ASX: OVN) is another health care stock which develops oral devices for the therapeutic treatment of breathing disorders, especially sleep apnea. This serves as a great way to play rising sleep apnea awareness, through activities that consist of distribution and commercialization of O2Vent mono in Australia. Bypassing multiple obstructions from the nose, soft palate and tongue, its devices have an airway that delivers air to the back of the mouth. The company uses three-dimensional (3D) metal printing technologies to manufacture medical devices for catering to the sector. The incorporation year was 2015 and the company is based out of Swann Road, Indooroopilly, Australia.
Start discussion with value Investors for ASX Stock Market Investment and Opinion.
Cannabis companies that sell both medicinal weed and recreational pot. Marijuana stocks to look at. Marijuana mergers and acquisitions. Dispensary data analytics. Upcoming marijuana IPO’s
Those phrases have become increasingly common as marijuana legalization spreads.
Global spending on legal cannabis is expected to grow 230% to $32 billion in 2020 as compared to $9.5 in 2017, according to Arcview Market Research and BDS Analytics. As of June 29, 2018 the United States Marijuana Index, despite a lot of uncertainty around regulations, has over the past 1 year gained 71.49%, as compared to about 12% gain seen by the S&P 500. Click here for your FREE Report